Atlas Trials

DREPAMASSE Study - Evaluation of a Newborn Screening for Sickle Cell Disease by Tandem Mass Spectrometry

Clinical trial NCT03985501 · COMPLETED

Trial details

NCT number
NCT03985501
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Study type
OBSERVATIONAL
Sickle Cell DiseaseInfant, Newborn, DiseaseDrepanocytosis
Start date
2021-03-16
Primary completion
2022-12-10
Enrollment
1431

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.